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Host-probiotic interaction: 
new insight into the role of the 
endocannabinoid system by in vivo 
and ex vivo approaches
Giorgia Gioacchini1, Giacomo Rossi2 & Oliana Carnevali1,3
The endocannabinoid system plays an important role in regulating inflammation in several chronic or 
anomalous gut inflammatory diseases. In vivo and ex vivo studies showed that 30 days treatment with a 
probiotic mix activated the endocannabinoid system in zebrafish. These results highlight the potential 
of this probiotic mixture to regulate immune cell function, by inducing gene expression of toll-like 
receptors and other immune related molecules. Furthermore, TUNEL assay showed a decrease in the 
number of apoptotic cells, and this finding was supported by a reduction in pro-apoptotic factors and an 
increase in anti-apoptotic molecules. The results presented here strengthen the molecular mechanisms 
activated by probiotic mix controlling immune response and inflammation.
A number of recent findings have shown that the endocannabinoid system (ECS) represents an alternative way 
to control and regulate the immune system and inflammation1. The ECS is a complex endogenous signalling net-
work, which includes cannabinoid receptors (endocannabinoid receptor 1 [Cnr1], endocannabinoid receptor 2 
[Cnr2] and capsaicin receptor transient potential vanilloid receptor 1 [Trpv1]), endogenous ligands (anandamide 
[AEA] and 2-arachidoonoyl-glycerol [2-AG]) that bind and activate the ECS receptors, and enzymes that either 
synthesize endocannabinoids (abhydrolase domain containing 4 [Abhd4]) or degrade them (fatty acid amide 
hydrolase [Faah] and monoacylglycerol lipase [Mgll])2. The ECS has pro-homoeostatic actions in the brain and 
the periphery affecting the immune system, autonomic nervous system, endocrine network, reproductive system 
and gastrointestinal function1, 3, 4. Its role in the regulation of the immune system is well established. In particular, 
it was demonstrated that all immune cells are able to synthetize, degrade or secrete endocannabinoids and possess 
cannabinoids receptors5. It has also been suggested that the ECS controls immune response activity by affecting 
toll-like receptor (Tlr) induced signalling, which in turn may regulate innate immune cell functioning and subse-
quent inflammatory events; however, the molecular evidence for this is still weak6.
Deficiencies in the ECS are associated with pathological states including irritable bowel syndrome7, colorectal 
carcinoma8 and celiac disease9. Clinical endocannabinoid deficiency syndromes (CEDS) may be improved by 
enhancing the ECS. Possible clinical approaches may include drugs or natural products able to increase biosyn-
thesis of ECS ligands or decrease their degradation, or alternatively, modulate the density or function of receptors.
The emerging perception that the gut microbiota plays a central role in regulating many physiological process 
within the host has supported the importance of the probiotic concept.
Probiotics have been defined as live microorganisms that, when administered in proper amounts, improve 
host health10. The role of the intestinal microbiota in the modulation of the ECS and intestinal pain has been 
demonstrated in different experimental models11, 12. The probiotic formulation selected for this study was VSL#3 
containing 450 billion of a mixture of Lactobacilli, Bifidobacteria, and Streptococcus thermophilus (commercial-
ized in EU as Vivomixx® and in USA as Visbiome®). This probiotic mixture was selected for this study because of 
its recognized clinical potential in the treatment of several gastrointestinal inflammatory diseases13–15. Although 
the mechanism of action of VSL#3 is not fully understood several studies performed on animal models have 
shown that VSL#3 modulates the host immune response. In particular VSL#3 is a potent inducer of IL-10 in 
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intestinal and blood dendritic cells and inhibits the generation of pro-inflammatory T helper cells16. It appears 
the protective effects of VSL#3 may be mediated by the DNA isolated from bacterial components of VSL#3 rather 
than by their metabolites or ability to colonise the colon. It was demonstrated that the anti-inflammatory effect of 
VSL#3 was dependent on non-methylated bacterial DNA (CpG) signalling acting via the toll-like receptor (TLR)-917. 
The aim of the study was to provide, by in vivo and ex vivo experiments, new insights into the molecular mech-
anisms through which VSL#3 probiotics can be recognized as non-pathogen microbes and can activate the 
immune response without causing inflammation. The zebrafish, Danio rerio, has gained considerable attention 
as an experimental model in biomedical research18. The availability of germ-free species, the resemblance of its 
physiology to that of mammals, the high similarity of immune system molecules to those in other vertebrates 
including mammals19–21, together with the high throughput capability in genetic and chemical screens, give 
zebrafish research a significant impact in promoting the development of personalized and precision medicine. 
Zebrafish colonization is characterized by a condition very similar to that of human. To investigate the effect of 
microbial colonization on the zebrafish host, Rawls and colleagues22 reared germfree zebrafish and investigate 
gene expression profiles. They showed that colonization altered the expression of 212 genes. Of these 212 genes, 
59 responses were conserved between human, mice and zebrafish. These conserved genes were mainly involved in 
epithelial proliferation, promotion of nutrient metabolism, and innate immune responses. This indicates that the 
response towards microbes is in part highly conserved in all these species, especially the pathways here studied.
Results
Effects of VSL#3 on intestinal epithelium integrity. Healthy fish exposed to VSL#3 for 4 weeks 
showed similar behaviour and survival to controls. Morphological study of intestines of VSL#3-treated zebrafish 
revealed substantial integrity of gut mucosa comparable to that of controls, without any inflammatory infiltrate 
or reactive status to probiotics (Fig. 1A,B).
The histological analysis showed an intact epithelial barrier with a columnar uniform epithelial and regular 
apical brush border without signs of damage in the intestines exposed to probiotic. In addition, after VSL#3 treat-
ment significant differences were seen in enterocyte length, villus length and crypt depth (Table 1S).
Moreover, TUNEL assay showed a high apoptotic rate among epithelial and mesenchymal cells in gut from 
control fish with respect to treated ones (Fig. 1C,D). The reduction in the apoptotic process in intestinal epithe-
lium after probiotic administration was also confirmed at molecular level by the lower expression of pro-apoptotic 
signals such as casp3 and baxa, concomitantly with an increase in anti-apoptotic signals such as bcl2a (Fig. 1E–G).
Effects of VSL#3 on the endocannabinoid system: an in vivo approach. Figures 2 and 3 show 
modulation of the ECS after VSL#3 administration. IHC analysis of gut sections from treated animals highlighted 
strong presence of Cnr1 in epithelial cells, in some mesenchymal cells, and in the ganglia of the muscular layer 
of the intestine wall. In contrast, gut sections from control animals showed a strong stain only in parietal ganglia, 
with markedly low levels of expression in enterocytes or other cell types (Fig. 2A–E). At molecular level, the 
involvement of VSL#3 administration on endocannabinoids synthesis and degradation was shown firstly in the 
gut. A significant increase of abhd4 gene expression was observed, coding for a key enzyme involved in AEA 
synthesis. Concomitantly, gene expression of faah and mgll, which code for the enzymes involved in degradation 
of AEA and 2-AG respectively, was significantly decreased after VSL#3 treatment. Moreover, molecular changes 
to endocannabinoid receptors cnr1 and cnr2 in zebrafish gut as consequence of VSL#3 administration were also 
observed while, the trpv1 gene was not affected (Fig. 3A–F).
Effects of VSL#3 on toll-like receptor activation. In zebrafish intestine, 30 days of probiotic admin-
istration induced a significant (p < 0.001) increase in gene expression levels of key molecules that can recognize 
microbes in the intestine such as tlr1, tlr2 and tlr9, with respect to control animals (Table 1A). The increase in 
gene expression was consistent with the increase at protein level found by immunohistochemistry with the excep-
tion of Tlr2, which showed no significant changes (Table 1B).
IHC analysis showed intense and diffuse presence of Tlr3 in the mucosal epithelium of treated animals. In 
sections from these animals it is evident that the stain was present in a continuous and constant pattern and 
almost exclusively localized along the superficial margin of enterocytes. In contrast, sections from control animals 
were characterized by weak and irregular Tlr3 presence in the enterocyte, without any staining of cell free pole 
membranes (Fig. 4A,B).
Effects of VSL#3 on immune response activation. Figure 4 and Table 1A,B illustrate modulation of 
the immune response after VSL#3 administration. In particular, gut from treated animals showed an increase in 
both gene and protein levels of molecules implicated in the innate immune response such as Il1b, Tnfa and Myd88 
(Table 1A,B). In addition, both mRNA of il10 and casp1, and their protein levels, were significantly (p < 0.001) 
higher in VSL#3-treated fish than controls (Table 1A,B). Using IHC analysis on gut from treated animals, Nos2a 
protein was localized specifically in endothelial cells or in macrophages, and to a lesser extent in epithelial cells. In 
control gut there was substantial negativity for the presence of Nos2a, both in the epithelium and in endothelial 
cells. (Fig. 4C,D); conversely, an increase of both protein and mRNA level for Nos2a was seen in VSL#3-treated 
fish (Table 1A,B). Concomitantly, the increase at both gene and protein level of signals involved in antigenic “tol-
erance” such as Tgfb1a and Nfkb was registered (Table 1A,B). In VSL#3-treated fish, IHC analysis showed higher 
Tgfb1a protein signal that appeared diffusely localized throughout the epithelium and in mononuclear cells with 
respect to control ones (Fig. 4E,F). Finally, the p65 subunit of the Nfkb heterodimer was found to be localized 
in a large proportion of enterocytes and in many mononuclear cells infiltrating the lamina propria of intestinal 
mucosa of VSL#3-treated fish, while in control gut it was restricted to scattered epithelial cells (Fig. 4G,H).
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Effects of VSL#3 on the endocannabinoid system: an ex vivo approach. Figures 5 and 6 illustrate 
modulation of ECS, immune response and inflammation after ex vivo exposure of zebrafish intestine. Eight hours 
of in vitro VSL#3 treatment on ex vivo intestine samples significantly increases cnr1, cnr2, faah, tlr2, il1b and casp3 
gene expression, confirming the stimulatory role of the probiotic. In contrast, 8 hours of exposure to AM251, 
a Cnr1 antagonist, induced in these samples a significant reduction of cnr1, cnr2, and il1b expression, without 
affecting faah and casp3 gene expression or the apoptotic rate evidenced by TUNEL. Finally, the concomitant 
exposure of intestine to VSL#3 and AM251 in the ex vivo assay showed a significant decrease in cnr1, tlr2 and 
il1b gene expression and in apoptotic rate, without affecting cnr2, faah and casp3 gene expression (Figs 5 and 6).
Discussion
Chronic or anomalous gut inflammation is the primary cause of many gut inflammatory diseases, including 
ulcerative colitis and Crohn’s disease, and it has been clearly shown that the endocannabinoid system plays an 
important role in modulating this inflammation9, 23–25. In particular, Di Marzo and Izzo26 demonstrated that cnr1 
and cnr2 activation may limit inflammation on well-established models of IBD in rodents. Data from several trials 
(reviewed by Chapman et al.13) suggested that VSL#3 has clinical potential in the treatment of many gut inflam-
matory diseases, but the mechanisms by which it exerts its beneficial role are not fully elucidated.
Until now no publications are reported in literature, that indicate studies regarding endocannabinoid system 
organization in gastrointestinal tract and its modulation by the microbiome in zebrafish. Meanwhile, given that 
several gut functions and immune genes are conserved between zebrafish and mammals, the zebrafish is an inter-
esting model organism to investigate fundamental processes underlying intestinal inflammation and injury27. 
In this context, the similarities of this model with mammal and rodent strongly suggest to consider relevant 
our results regarding distribution and role of endocannabinoid receptors in ZF. These results are relatable to 
Figure 1. (A) Paraphysiological morphology of intestinal wall in untreated control zebrafish (bar = 200 µm). 
(B) Morphology of intestine of VSL#3-treated zebrafish reveals good integrity of the gut mucosa, without any 
inflammatory infiltrate or reactive status to probiotics (bar = 200 µm). (C) In section of gut of untreated fish, 
a high apoptotic rate evidenced by TUNEL is evident among epithelial and mesenchymal cells, with nuclear 
intense black stain (bar = 200 µm). (D) TUNEL analysis of section of VSL#3-treated intestine revealed that some 
enterocytes and mesenchymal cells are going into apoptosis, showing their nuclei intensively black stained by 
the chromogen (arrow heads, bar = 200 µm). Intestinal (E) casp3, (F) baxa and (G) bcl2a mRNA levels by qPCR 
normalized against act1b and rplp, in control and VSL#3-treated fish. Values indicate mean ± SD. ***p < 0.001 
****p < 0.0001.
www.nature.com/scientificreports/
4Scientific RepoRts | 7: 1261  | DOI:10.1038/s41598-017-01322-1
that which would be the endocannabinoid expression in humans or mice GI tract. The results obtained here in 
zebrafish intestine are in agreement with the previous reports from Rousseaux and collaborators11 done both in 
vitro in human HT-29 epithelial cells and both in vivo in Balb/c mice and Sprague Dawley rats, showed the ability 
of Lactobacillus acidophilus to induce intestinal cannabinoid receptors, and from Distrutti and co-workers28 who 
reported increased cnr1 gene expression in mouse colon after VSL#3 administration.
In the present study, we offer evidence that in control intestine, cnr1 presence was only detectable in ganglia, 
while in VSL#3-treated gut, Cnr1 was also present in epithelial cells and in some mesenchymal cells. Interestingly, 
as suggested by Sibaev et al.29 it should be noted that in our experiments, spindle-shaped cnr1 immunopos-
itive cells, encountered within the outer muscle layer, were systematically ckit/GFAP/S100 immunonegative 
(data not shown), demonstrating that interstitial cajal cells (ICC) are not involved in this VSL#3-induced cnr1 
overexpression.
The anti-inflammatory capability of VSL#3 was indicated by the positive modulation of cnr2 concomitantly 
with the constant level of trpv1 genes on zebrafish intestine. In fact, the importance of Cnr2 receptor activation 
in the immune-modulatory effects of endocannabinoids has been well recognized, and its anti-inflammatory role 
is evident in many pathological conditions such as inflammatory pain and gastrointestinal inflammatory disor-
ders30. In addition, it has been shown that Trpv1 binding AEA induces inflammation in the gut31.
In the present study, it was demonstrated that in zebrafish, probiotics included in the VSL#3 formulation 
communicate with the host by activating Tlrs as demonstrated in others species17. Chu and Mazmanian32 noted 
in a review that Tlrs, being pattern-recognition receptors (PRR), may have evolved to mediate the bi-directional 
cross talk between “good” bacteria and their hosts. In particular, in zebrafish the PRR system is highly similar to 
that in other vertebrates and tlr orthologs have been identified and well characterized in this fish species33, 34. Key 
features of the fish Tlrs and the factors involved in their signalling cascade have high structural similarity to the 
mammalian Tlr system. The ligand specificity of several Tlr receptors is highly conserved in all vertebrates35. Most 
vertebrate genomes are recognized to have at least one gene representing each of the seven major tlr1, tlr2, tlr3, 
tlr4, tlr5, tlr7 and tlr11 families36 but the most conserved among zebrafish and human and other mammals mod-
els are tlr1, 2 3 and 934. In particular, after microbial identification, all Tlrs with the exception of Tlr3 trigger the 
activation of intracellular pathways, which is myeloid differentiation factor 88 (Myd88)-dependent37. In this case, 
Myd88, through the activation of nuclear factor Nfkb, induces production of pro-inflammatory cytokines includ-
ing Il1b and Tnfa37. The interaction of a probiotic, such as E. coli Nissle with Tlr2 and Tlr4 was previously found in 
mammals38, but here for the first time we have established the ability of VSL#3 to communicate with the host by 
activating several tlrs in zebrafish. In particular, VSL#3 administration activated Tlr1 and 2, respectively involved 
Figure 2. (A,C) Section from untreated fish, stained for cnr1 receptor, shows a strong stain restricted to parietal 
ganglia only (arrow head), with low levels of expression in enterocytes or other cell types (A-bar = 200 µm; C- 
bar = 50 µm). (B) Strong expression of cnr1 is observed in epithelial cells, in some mesenchymal cells, and in 
ganglia (arrow heads) of the muscular layer of intestine wall of VSL#3-treated fish (bar = 200 µm). (D) Note the 
strong presence of the receptor in a ganglion, as demonstrated by high power magnification of a particular area 
in the same section (bar = 50 µm). (E) Intestinal cnr1 protein levels by IHC in control and VSL#3-treated fish. 
Values indicate mean ± SD. ***p < 0.001.
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in the recognition of cell-surface bacterial peptidoglycans and lipoproteins both in mammal and fish39. Moreover, 
Tlr3 and 9, which are nucleic acid-sensing and recognize nucleotides from both viruses and bacteria17, 40, were acti-
vated after VSL#3 administration. The activation of these receptors by VSL#3, in particular Tlr2 and Tlr9, has been 
related to immune system activation without triggering a negative inflammatory response. Tlr2 is widely described 
as a PRR, mediating host protective immune responses41, 42. Interestingly, not all Lactobacilli strains can activate Tlr2, 
suggesting that strain-specific immunoregulatory effects may be partially mediated via Tlr2 activation43, 44.
Results obtained with our zebrafish model, when treated with VSL#3, show on the one hand an 
over-stimulation of tlr2 and tlr9 and respective proteins, and on the other hand increased expression of some 
inflammatory cytokines, but without histological signs of mucosal inflammation and damage. These results 
are in line with previous observations in macrophages on the ability of some probiotics, such as L. rhamno-
sus GG, to moderately activate the production of inflammatory cytokines and the transcription factors involved 
in humans45–48, but at the same time to prevent a detrimental intestinal inflammatory response. Bacteria con-
tained in the VSL#3 mixture (Streptococcus thermophilus DSM 24731, Bifidobacterium longum DSM 24736, 
Bifidobacterium breve DSM 24732, Bifidobacterium infantis DSM 24737, Lactobacillus acidophilus DSM 24735, 
Lactobacillus plantarum DSM 24730, Lactobacillus paracasei DSM 24733, Lactobacillus delbrueckii subsp. bulga-
ricus DSM 24734), similarly to LC705 and GG, are able to upregulate genes and protein levels for inflammatory 
cytokines Il1b and Tnfa in zebrafish, as recently reported in mice49, 50. Moreover, anti-inflammatory genes such 
as il10 and tgfb1a and genes for transcription factors such as nfkb, were affected by probiotic administration51. 
The anti-inflammatory effect exerted by VSL#3 highlighted in our study was supported by the maintenance of 
intestinal epithelial integrity, shown by histological analysis. In addition, the reduced apoptosis rate shown by 
TUNEL assay, as well as the reduced level of pro-apoptotic signals such as casp3 and baxa, concomitantly with the 
increase in anti-apoptotic signals such as bcl2a52–54 support the anti-inflammatory role of VSL#3. Although single 
epithelial cell apoptosis and elimination without loss of barrier permeability are normal physiological events in 
the gastrointestinal tract55, an increased epithelial apoptotic ratio might be cause of relevant leaks in the epithelial 
barrier. Uncontrolled cell cycle or apoptosis are often the main mechanisms in pathogenesis of cancers, autoim-
mune diseases or chronic inflammation56–58. Our results are in agreement with some previously obtained in a 
murine model after VSL#3 treatment showed a decreased apoptosis in intestinal epithelial cells59.
In our results, the induction by VSL#3 administration of il1 and tnfα associated with casp1 expression resulted 
in an anti-apoptotic final outcome. These results are in accordance with the recent observation that casp1 activa-
tion fails to trigger pyroptosis in all cell types, and somewhat surprisingly, epithelial cells use casp1 activation to 
Figure 3. Intestinal (A) cnr1, (B) cnr2, (C) trpv1, (D) abhd4, (E) faah and (F) mgll mRNA levels by qPCR 
normalized against act1b and rplp, in control (CTRL) and VSL#3-treated (VSL#3) fish. Values indicate 
mean ± SD. *p < 0.05; ***p < 0.001.
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prevent cell death60. The function of casp1 is analogous to the activities of other apoptotic caspases (Casp3 and 8) 
in modulating the fate of certain cell types61. Low levels of casp1, as probably occurred in our case, stimulate cell 
survival responses, control intracellular bacterial growth and mediate inflammatory cytokine production. When 
casp1 activation reaches a critical threshold level, cells undergo pyroptosis and release inflammatory intracellular 
contents. To our knowledge, our study is the first to conduct an ex vivo study of zebrafish intestine. We compared 
histological integrity and apoptotic signals in control intestine before and after 8 hours of in vitro culture and no 
significant differences were found, clearly indicating that such culture methods are a valid and reliable tool to 
study the direct effects of bacteria on intestine.
The results achieved by the ex vivo studies clearly showed that the immune stimulant and anti-inflammatory 
role of VSL#3 is mediated by the activation of the endocannabinoid system. After 8 hours of in vitro VSL#3 expo-
sure, a clear induction of cnr1, cnr2, tlr2 and il1b genes was found, concomitantly with a reduction in casp3 gene 
expression and TUNEL positive cells, confirming the in vivo study results. At the same time, the lower cnr1 levels 
induced by AM251 exposure in cultured intestine were related to a decrease in immunerelated gene expression 
and an increase in apoptotic signal (casp3 and TUNEL-positive cells). The simultaneous addition of VSL#3 and 
AM251 to the culture medium did not re-establish the levels of signals found in the intestine exposed to VSL#3, 
strengthening the concept that it acts through the activation of endocannabinoid system.
Concluding, the endocannabinoid system is recognized as an anti-inflammatory agent, with identified protec-
tive roles in many inflammatory diseases. In the present study, we report in vivo and ex vivo results that provide 
a novel molecular network through which probiotics such as VSL#3 activate the endocannabinoid system and 
induce Tlr signalling. These results further highlight the potential of this probiotic mixture to regulate immune 
cell functioning, decreasing detrimental effects and consequent inflammatory events in zebrafish. Considering 
Gene name Pathway involved Control VSL#3
Il1b Inflammatory cascade 1.29 ± 0.33 14.51 ± 2.69***
tnfa Inflammatory cascade 1.04 ± 0.21 2.59 ± 0.44***
myd88 Production of pro-inflammatory cytokines 1.24 ± 0.36 3.15 ± 0.35***
Il10 Anti-inflammatory action 1.54 ± 0.84 13.58 ± 2.89****
casp1
Stimulation of cell survival responses, 
control intracellular bacterial growth and 
modulation of inflammatory cytokine 
production
2.14 ± 0.84 8.75 ± 1.89****
nos2a Protective role in intestinal inflammation 1.09 ± 0.21 3.73 ± 0.30***
tgfb1a Anti-inflammatory action 1.29 ± 0.12 3.02 ± 0.37****
nfkb Production of pro-inflammatory cytokines 1.48 ± 0.36 2.98 ± 0.21***
tlr1 Recognition of cell-surface bacterial peptidoglycans 2.08 ± 1.02 36.75 ± 4.17***
tlr2 Recognition of cell-surface bacterial lipoproteins 1.30 ± 0.35 19.59 ± 3.35***
tlr3 Nucleic acid-sensing and recognition nucleotides from both viruses and bacteria 1.12 ± 0.36 13.22 ± 3.74*
tlr9 Nucleic acid-sensing and recognize nucleotides from both viruses and bacteria 1.42 ± 0.51 17.07 ± 2.43*
Protein name Control VSL#3
Il1b Inflammatory cascade 7.46 ± 3.23 24.26 ± 6.30***
Tnfa Inflammatory cascade 38.23 ± 13.24 94.26 ± 16.37***
Myd88 Production of pro-inflammatory cytokines 9.06 ± 4.23 23.33 ± 6.30**
Il10 Anti-inflammatory action 12.58 ± 4.33 32.58 ± 3.69****
Casp1
Stimulation of cell survival responses, 
control intracellular bacterial growth and 
modulation of inflammatory cytokine 
production
9.85 ± 3.84 51.68 ± 15.63***
Nos2a Protective role in intestinal inflammation 2.61 ± 2.41 31.55 ± 10.51****
Tgfb1a Anti-inflammatory action 2.06 ± 1.27 43.84 ± 16.74****
Nfkb Production of pro-inflammatory cytokines 38.71 ± 15.43 87.72 ± 16.47***
Tlr1 Recognition of cell-surface bacterial peptidoglycans 5.35 ± 3.55 24.55 ± 5.57****
Tlr2 Recognition of cell-surface bacterial lipoproteins 9.61 ± 4.43 15.35 ± 8.94
Tlr3 Nucleic acid-sensing and recognition nucleotides from both viruses and bacteria 1.45 ± 1.01 21.66 ± 9.55****
Tlr9 Nucleic acid-sensing and recognize nucleotides from both viruses and bacteria 20.43 ± 9.92 39.92 ± 12.44****
Table 1. (A) Intestinal mRNA levels tested by qPCR and (B) protein levels by IHC of immune system and 
inflammatory related molecules, in control (CTRL) and VSL#3-treated (VSL#3) 129 fish. Values indicate mean ± SD. 
*p < 0.5; **p < 0.01; ***p < 0.001; ****p < 0.0001.
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Figure 4. (A) Intestine section from untreated fish; note the evident reduction in intensity of tlr3 staining 
with respect to VSL#3-treated fish, characterized by a weak and irregular enterocyte expression, without any 
staining of cell free pole membranes (bar = 200 µm). (B) Intestine section from treated fish; note the intense 
and diffuse presence of tlr3 in the mucosal epithelium. The stain is almost exclusively restricted along the 
superficial margin of enterocytes (arrow heads), and shows a continuous and constant pattern (bar = 200 µm). 
(C) In section from untreated fish, note the substantial negativity for the presence of Nos2a, both in the 
epithelium and in endothelial cells (bar = 200 µm). (D) In intestine section from treated fish, an evident 
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the availability of a zebrafish model of IBD and related diseases62, the results discussed here could be the basis for 
further studies on IBD induced zebrafish.
Methods
In vivo fish maintenance and VSL#3 treatment. Adult male zebrafish specimens purchased from a 
local supplier (Acquario di Bologna, Bologna, Italy) were acclimated to laboratory conditions and their health 
state was monitored for four weeks prior to the beginning of the experiments.
Fish were divided into a control group (CTRL), which was fed with commercial food, and a probiotic-treated 
group (VSL#3), that received a commercial diet containing the lyophilized probiotic at a final concentration of 
109 CFU/g for 30 days. The probiotic formulation utilized was VSL#3 (produced before January 31, 2016; VSL 
Pharmaceuticals, Inc., Gaithersburg, MD, USA). Probiotics contained 450 × 109 live bacteria (Streptococcus ther-
mophilus DSM 24731, Bifidobacterium longum DSM 24736, Bifidobacterium breve DSM 24732, Bifidobacterium 
infantis DSM 24737, Lactobacillus acidophilus DSM 24735, Lactobacillus plantarum DSM 24730, Lactobacillus 
paracasei DSM 24733, Lactobacillus delbrueckii subsp. bulgaricus DSM 24734).
The probiotic strain was mixed into the diet prior to feeding. All fish were served with a quantity of food 
ranging from 1.5% to 2% of their bodyweight per day. The experiment was conducted in triplicate and for each 
replicate tank, the final housing density was 20 males.
All the procedures involving animals were conducted in accordance with the Italian law on animal experi-
mentation and were approved by the Ethics Committee of Università Politecnica delle Marche (Prot #63/INT/
CESA12-16). All efforts were made to minimize suffering.
After 30 days of treatment, ten males from each experimental group were sacrificed by a lethal overdose of 
anesthesia (500 mg/L MS-222 [3-aminobenzoic acid ethyl ester] buffered to pH 7.4; Sigma).
Five intestines from each experimental group were removed and fixed in PFA fixative. The remaining intes-
tines were sampled for histology, immunohistochemistry and q-PCR assay.
Ex vivo tissue culture. Twenty-four control fish were sacrificed after a 12-hr fast by a lethal overdose of 
anesthesia (as above). Intestines were excised and placed in a tissue culture dish of 35 × 10 mm (Falcon). The 
medium employed in these cultures consisted of 9 parts Dulbecco’s modified medium (DMEM)/Ham’s F12 
(Sigma) and 1 part fetal calf serum (Sigma). In addition, 10,000 U of crystalline penicillin G and 0.01 g of strep-
tomycin sulfate (Sigma) were added to each 100 ml of medium. The intestines were cultured in the presence of 
antibiotics for 4 hours and then placed in a new tissue culture dish in the same medium without the antibiot-
ics. For experimental purposes, incubations were carried out separately in Dulbecco’s Modified Eagle Medium 
(DMEM) (Thermo Fisher Scientific) (CTRL), DMEM + VSL#3 (final concentration 109 CFU/ml) (VSL#3), 
DMEM + AM251 (Cayman Chemical) (10 nM) (AM251), and DMEM + VSL#3 + AM251, (VSL#3 + AM251). 
AM251 concentration was chosen on the basis of previous studies63, 64.
The dishes were covered, placed on a steel rack set in a McIntosh jar (Scientific Products, Inc., Los Angeles, 
CA) and maintained at 37 °C. The jar was gassed with 95% 02 and 5% C02 for 20 min and then sealed. Intestines 
from each experimental group were sampled for histology, immunohistochemistry and q-PCR assay after 8 hours 
of culture.
A 5 mm-long piece from the anterior part of each ex-vivo cultured gut was used also for morphological evalu-
ations, after dissection and a 10% buffered formalin fixing procedure and immunohistochemistry analysis.
Histology. PFA-fixed samples were processed for routine histology to obtain a transversal section, which was 
stained with hematoxylin and eosin (H&E). Sections were evaluated under a light microscope (Carl Zeiss, Jena, 
Germany) for any degenerative and/or inflammatory changes.
Villus length, crypt depth, villus length/crypt depth ratio and enterocyte length were determined from three 
fish per group; 50 images were taken for each intestine, for a total of 150 images per group, and 12 enterocytes 
were measured per image. Enterocyte lengths were measured starting from their basal membrane connected with 
the lamina propria up to the free, luminal pole of the cell. All measurements were taken from micrographs using 
the Software Image J. In all cases, measurements were made using sections in which villi, cryptae, and enterocytes 
were cut along their entire length; only crypts or villi that were sagittally sectioned along their entire length were 
scored. For enterocytes, the cell was considered complete when the nucleus was visible and aligned, to ensure that 
the section plane was appropriate.
Immunohistochemistry (IHC) analysis. For immunohistochemical evaluations, paraffin sections of 
zebrafish gastrointestinal tract were rehydrated and neutralized for endogenous peroxidases with 3% hydrogen 
presence of Nos2a is observed, especially in endothelial cells (large arrows) or in scattered mononuclear cells 
(presumably macrophages) interspersed throughout the mucosal chorion (arrow heads). Note the molecule is 
also localized in some epithelial cells (small arrow); (bar = 200 µm). (E) Untreated zebrafish show low level of 
immunoreactivity for Tgfb1a both in the epithelium and in mononuclear cells (bar = 200 µm). (F) In VSL#3-
treated fish, intestinal presence of Tgfb1a was strong and diffuse throughout the epithelium (large arrows) and 
in some mononuclear cells (small arrows); (bar = 200 µm). (G) In untreated fish the localization of the p65 
subunit of the Nfkb heterodimer is restricted to scattered epithelial cells (bar = 200 µm). (H) Similarly to Tgfb1a 
localization, the p65 subunit of the Nfkb heterodimer is present in a large proportion of enterocytes (large 
arrows). Also note the presence of this marker in many mononuclear cells (small arrows), infiltrating the lamina 
propria of the intestinal mucosa of VSL#3-treated zebrafish (bar = 200 µm).
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peroxide for 5 minutes followed by rinsing for 5 minutes in distilled water. For antigen retrieval, slides were incu-
bated in three antigen retrieval solutions: citrate buffer (pH 6.0) for tgfb1a, nfkb, and tlrs; EDTA (pH 8.0) for 
myd88; and 0.01 M Tris-EDTA buffer (pH 9.0) for anti-cnr1, anticnr2, anti-casp3, and anti-casp1 in a steamer 
(Black & Decker, Towson, MD) for 20 minutes. Non-specific binding was blocked by incubation of slides for 
10 minutes with a proteinblocking agent (Dako, Carpinteria, CA) before application of the primary antibody. 
All antibodies used were specific for zebrafish, or previously tested and reactive also for this species. Slides were 
incubated overnight in a moist chamber with the following primary antibodies: polyclonal (pAb) rabbit anti-cnr1 
(AB9415, Anti-Cannabinoid Receptor 1 Antibody, Millipore Merck, USA) diluted 1:100; pAb anti-cnr2 (PA5-
33445, CNR2/CNR2, Thermo Scientific, Rockford, USA) diluted 1:100; anti-tlr3 (CT) (AS-55356, Z-Fish™, 
Eurogentec), and anti-tlr9 (IN), (AS-55351, Z-Fish™, Eurogentec), both used at dilution of 1:500; anti-tlr1 
(Zebrafish antibodies, Berkeley Heights, USA), and anti-tlr2 (Zebrafish antibodies, Berkeley Heights, USA), both 
used diluted at 1:50; anti-myd88 (CT) (Z-Fish™), anti-casp3 (p12) (CT) (Z-Fish™), anti-casp1 (Z-Fish™), anti 
tgfb1a (Z-Fish™), all used at dilution of 1:50; pAb anti-nfkb p65 - N-terminal (ab177895, ABCAM), at dilution of 
1:200; and pAb anti-nos2a (610332, BD Pharmingen, San Diego, CA) used at dilution of 1:500.
The immunoreaction with streptavidin–immunoperoxidase (Streptavidin–immunoperoxidase, Black & 
Decker, Towson, MD) was visualized with 3,3′-diaminobenzidine substrate (Vector, Burlingame, UK). Tissues 
were counterstained with Mayer’s hematoxylin. For negative immunohistochemical controls the primary anti-
bodies were omitted. Sections of zebrafish and killifish spleen and kidney served as positive control tissues for 
TUNEL, casp1 and 3, tgfb1a, and myd88 cell staining. Positive control tissues for tlrs staining consisted of fish 
skin and gills sections. For scoring of intestinal parameters such as cnr1- and cnr2-receptor positive cells, tlrs, 
tgfb1a+, myd88+, nos2a+, and nfkb+ cells, the cells were quantified in the small intestinal compartment of the 
GI tract (anterior portion of the intestine: villi, basal crypt area, villuscrypt junction) as previously reported21. 
Similar evaluations were performed in an attempt to evaluate the Caspase3, Caspase1 and TUNEL+ cells. All cell 
types were evaluated using a light microscope (Carl Zeiss, Jena, Germany), a × 40 objective, a × 10 eyepiece, and 
a square eyepiece graticule (10 × 10 squares, having a total area of 62,500 μm2). Ten appropriate fields were chosen 
for each compartment and arithmetic means were calculated for each intestinal region. Results were expressed as 
IHC positive cells per 62,500 μm2. For all parameters, cells on the margins of the tissue sections were not consid-
ered for evaluation to avoid inflation of positive cell numbers.
Figure 5. Intestinal mRNA levels evaluated by qPCR of (A) cnr1, (B) cnr2, (C) faah, (D) tlr2, (E) casp3 and (F) 
il1b normalized against act1b and rplp, in different experimental groups from ex vivo experimentation. Values 
indicate mean ± SD. Different letters denote significant differences among groups.
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For the evaluation of different cnr1 and 2 and tlrs subsets in the same histological sections, consecutive 
3-μm-thick bioptic cross-sections were cut. Sections were placed consecutively on each of eight separate slides, 
after which the ninth section was placed on the first slide, next to the first section, continuing for 48 sections. A 
single slide, upon which were six bioptic cross-sections from each fish, was analysed for any given immunostain. 
Numbers of cnr1+, cnr 2+, tlrs (1,2,3,9)+, tgfb1+, casp3+ and cas1+ epithelial and/or immunocompetent cells 
were quantified by using an image analysis system consisting of a light microscope (Carl Zeiss, Jena, Germany) 
attached to a Javelin JE3462 high-resolution camera and a personal computer equipped with a Coreco-Oculus 
OC-TCX frame grabber and high-resolution monitor. Computerized color image analysis was performed using 
Image-Pro Plus software (Media Cybernetics). The area of each biopsy in all six cross-sections in every fish 
was recorded, as was the total number of epithelial positive cells determined by immunostaining as previously 
described. For each fish, the total immunostained cells were counted per section, and stained cell densities were 
expressed as the number of immunocompetent/epithelial cells per square millimeter of analyzed bioptic area65.
RNA extraction and cDNA synthesis. Total RNA extraction from intestinal tissues was performed 
following Falcinelli and coworkers66. Total RNA extracts were eluted in 30 μl of RNAse-free water. Final RNA 
concentrations were determined with a NanoDropTM 1000 Spectrophotometer (Thermo Scientific) and the 
RNA integrity was verified by ethidium bromide staining of 28 S and 18 S ribosomal RNA bands on 1% agarose 
gel. RNA was stored at −80 °C until use. Total RNA was treated with DNAse (10 IU at 37 °C for 10 min, MBI 
Fermentas). A total amount of 1 µg of RNA was used for cDNA synthesis, employing the iScript cDNA Synthesis 
Kit (Bio-Rad).
Real time PCR. PCRs were performed with the SYBR green method in an iQ5 iCycler thermal cycler 
(Bio-Rad Laboratories) following Gioacchini and coworkers67. Actin beta (act1b) and ribosomal protein, large, 
P0 (rplp) were used as internal standards in each sample in order to standardize the results by eliminating varia-
tion in mRNA and cDNA quantity and quality. No amplification products were observed in negative controls and 
no primer-dimer formations were observed in the control templates. The data obtained were analysed using the 
Figure 6. Intestinal distribution of cnr1 by IHC in different experimental groups from ex vivo experimentation: 
(A) Control; (B) VSL#3; (C) AM251; (D) VSL#3 + AM251. (E) Cnr1 protein levels by IHC and (F) TUNEL 
positive cell count in the same ex vivo experimental groups. Values indicate mean ± SD. Different letters denote 
significant differences among groups.
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iQ5 optical system software version 2.0 (Bio-Rad) including GeneEx Macro iQ5 Conversion and genex Macro 
iQ5 files. The primer sequences used are reported in Table 2S.
Statistical analysis. Data are presented as mean ± SD. Student’s t-test was used for comparison between the 
two experimental groups for in vivo experimentation. Two-Way ANOVA followed by the Tukey test as a multiple 
comparisons test was used for comparison among experimental groups for ex vivo experimentation. Statistical 
evaluation of enterocyte length, villus height, crypt depth and villus height/crypt depth ratio were tested by vari-
ance analysis and confirmed by nonparametric methods (Wilcoxon). All statistical analyses were performed using 
the statistical software package Prism5 (Graphpad Software, Inc. USA) with significance accepted at P < 0.05.
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